Federation des caisses Desjardins du Quebec’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-6,013	Closed	-$280K	–	2207
2017 Q3	$280K	Hold	6,013	–	–	﹤0.01%	940
2017 Q2	$298K	Hold	6,013	–	–	﹤0.01%	857
2017 Q1	$330K	Buy	+6,013	New	+$318K	0.01%	807

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BSTC Position: Q4 2017 in Review

Federation des caisses Desjardins du Quebec sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2017, closing a stake of 6,013 shares — an estimated $280K sold.

Federation des caisses Desjardins du Quebec first reported a position in BSTC in Q1 2017 and held it in 3 quarters. The position peaked at $330K in Q1 2017. 88 funds tracked by Wall St. Rank hold BSTC as of Q4 2017.

Federation des caisses Desjardins du Quebec reported no remaining BioSpecifics Technologies Corp. position as of Q4 2017 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 6,013 BioSpecifics Technologies Corp. shares in Q4 2017, an estimated $280K.
Federation des caisses Desjardins du Quebec first reported a position in BioSpecifics Technologies Corp. in Q1 2017 and held it in 3 quarters.
Federation des caisses Desjardins du Quebec's BioSpecifics Technologies Corp. position peaked at $330K in Q1 2017.
88 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2017.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2017, filed 30 Aug 2024.